Cladribine repurposed in multiple sclerosis: making a fortune out of a generic drug

Hans J C Buiter; Luc Derijks; Chris J J Mulder

doi:10.1136/ejhpharm-2019-002026

Cladribine repurposed in multiple sclerosis: making a fortune out of a generic drug

Eur J Hosp Pharm. 2019 Sep;26(5):246-247. doi: 10.1136/ejhpharm-2019-002026. Epub 2019 Aug 30.

Authors

Hans J C Buiter¹, Luc Derijks², Chris J J Mulder³

Affiliations

¹ Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
² Department of Clinical Pharmacy and Pharmacology, Maxima Medical Centre, Veldhoven, The Netherlands.
³ Department of Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.

No abstract available

Keywords: DMT; Purine nucleoside analogues; cladribine; cost; drug; immune suppression; multiple sclerosis; off-label; re-discovery; subcutaneous.

Publication types

Editorial